COMMON STOCK PURCHASE WARRANT CHINA JO-JO DRUGSTORES, INC.Common Stock Purchase Warrant • June 2nd, 2020 • China Jo-Jo Drugstores, Inc. • Retail-drug stores and proprietary stores
Contract Type FiledJune 2nd, 2020 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above1 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from CHINA JO-JO DRUGSTORES, INC., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 2nd, 2020 • China Jo-Jo Drugstores, Inc. • Retail-drug stores and proprietary stores • New York
Contract Type FiledJune 2nd, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 1, 2020, between China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIAL China Jo-Jo Drugstores, Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City People’s Republic of China 310008 Attn: Lei Liu, Chief Executive OfficerExclusive Agency Agreement • June 2nd, 2020 • China Jo-Jo Drugstores, Inc. • Retail-drug stores and proprietary stores • New York
Contract Type FiledJune 2nd, 2020 Company Industry JurisdictionThis letter agreement (this “Agreement”) constitutes the agreement between China Jo-Jo Drugstores, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement (each, an “Offering”). The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwr
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT CHINA JO-JO DRUGSTORES, INC.Placement Agent Common Stock Agreement • June 2nd, 2020 • China Jo-Jo Drugstores, Inc. • Retail-drug stores and proprietary stores
Contract Type FiledJune 2nd, 2020 Company IndustryTHIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 1, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from CHINA JO-JO DRUGSTORES, INC., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of May 31, 2020, by an between the Company and H.C. Wainwright & Co., LLC.